Multidrug resistance and stem cells in acute myeloid leukemia.
Sikic
Branimir I
BI
D051997:ADP-ribosyl Cyclase 1 / Q000276:immunology; D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000187:drug effects / Q000235:genetics / Q000276:immunology; D018952:Antigens, CD34 / Q000276:immunology; D001692:Biological Transport / Q000187:drug effects / Q000276:immunology; D001854:Bone Marrow Cells / Q000166:cytology / Q000187:drug effects; D003524:Cyclosporins / Q000494:pharmacology; D018432:Drug Resistance, Multiple; D020869:Gene Expression Profiling; D006412:Hematopoietic Stem Cells / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D008942:Mitoxantrone / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D014700:Verapamil / Q000494:pharmacology
C513055:ABCB1 protein, human; D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D018952:Antigens, CD34; D003524:Cyclosporins; D008942:Mitoxantrone; D014700:Verapamil; D051997:ADP-ribosyl Cyclase 1; C070272:valspodar